• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BioNTech mRNA 疫苗的先驱和成功合作伙伴。

The forerunners and successful partnerships behind the BioNTech mRNA vaccine.

机构信息

Institute of Bioorganic Chemistry, Polish Academy of Sciences, Z. Noskowskiego, 12/14, 61-704, Poznan, Poland.

NanoBioMedical Center, Adam Mickiewicz University, Poznan, Poland.

出版信息

J Appl Genet. 2024 Feb;65(1):47-55. doi: 10.1007/s13353-023-00793-5. Epub 2023 Oct 20.

DOI:10.1007/s13353-023-00793-5
PMID:37861886
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10789661/
Abstract

The discovery of nucleic acids stands as a paramount achievement in the history of scientific endeavors. By applying transformative advancements in the fields of chemistry and physics to biological systems, researchers unveiled the enigmatic nature of life. Notably, messenger RNA (mRNA) emerged as a crucial player in this profound revelation, serving as a transient intermediary for genetic information transfer between genes and proteins. Groundbreaking investigations carried out from 1944 to 1961 led to the initial identification of this pivotal molecule, captivating scientific interest for the past three decades. The field of mRNA research has witnessed a transformative shift owing to the development of cap analogs and nucleotide modifications. This revolutionary progress has fostered a new generation of potent therapeutics. Prior to the advent of the coronavirus pandemic, numerous scientists had already begun exploring the unique properties of mRNA. However, with the onset of the pandemic, mRNA catapulted into the limelight as a heroic agent, providing the foundation for highly effective vaccines that have played a crucial role in mitigating the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The successive generations of cap analogs have significantly enhanced the translation efficacy of mRNA, while the discovery of suitable purification, packaging, and delivery methods has paved the way for groundbreaking medical breakthroughs. Pioneers in the field such as Katalin Karikó, Drew Weissman, Edward Darzynkiewicz, Robert Rhodes, Ugur Sahin, and Ozlem Tureci have made significant contributions during the early stages of mRNA research, warranting acknowledgement for their visionary endeavors. The narrative of mRNA represents a remarkable journey marked by a succession of breakthroughs in a discipline that holds immense promise for the future of medicine. Thanks to the pioneering work of these exceptional scientists, we are well-positioned to unlock the full potential of this extraordinary molecule, ushering in a new era of medical advancements.

摘要

核酸的发现是科学发展史上的一项重大成就。通过将化学和物理学领域的变革性进步应用于生物系统,研究人员揭示了生命的神秘本质。特别是信使 RNA(mRNA)在这一深刻发现中扮演了关键角色,作为基因和蛋白质之间遗传信息传递的短暂中间体。从 1944 年到 1961 年进行的开创性研究导致了这种关键分子的初步鉴定,在过去的三十年里引起了科学界的极大兴趣。由于帽类似物和核苷酸修饰的发展,mRNA 研究领域发生了变革性转变。这一革命性进展催生了新一代有效的治疗方法。在冠状病毒大流行之前,许多科学家已经开始探索 mRNA 的独特性质。然而,随着大流行的爆发,mRNA 一跃成为英雄般的药物,为高效疫苗的研发奠定了基础,这些疫苗在减轻严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)传播方面发挥了关键作用。随后几代的帽类似物显著提高了 mRNA 的翻译效率,而合适的纯化、包装和递送方法的发现为突破性的医学突破铺平了道路。在 mRNA 研究的早期阶段,Katalin Karikó、Drew Weissman、Edward Darzynkiewicz、Robert Rhodes、Ugur Sahin 和 Ozlem Tureci 等领域的先驱者做出了重要贡献,他们的远见卓识值得肯定。mRNA 的发展历程是一个非凡的故事,标志着在一个具有巨大医学前景的学科中,连续取得了突破性进展。多亏了这些杰出科学家的开创性工作,我们才能充分挖掘这种非凡分子的潜力,迎来医学进步的新时代。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aca/10789661/380f6bb8009b/13353_2023_793_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aca/10789661/380f6bb8009b/13353_2023_793_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aca/10789661/380f6bb8009b/13353_2023_793_Fig1_HTML.jpg

相似文献

1
The forerunners and successful partnerships behind the BioNTech mRNA vaccine.BioNTech mRNA 疫苗的先驱和成功合作伙伴。
J Appl Genet. 2024 Feb;65(1):47-55. doi: 10.1007/s13353-023-00793-5. Epub 2023 Oct 20.
2
From rejection to the Nobel Prize: Karikó and Weissman's pioneering work on mRNA vaccines, and the need for diversity and inclusion in translational immunology.从被拒之门外到诺贝尔奖:卡里科和魏斯曼在 mRNA 疫苗方面的开创性工作,以及转化免疫学领域多样性和包容性的必要性。
Front Immunol. 2023 Nov 8;14:1306025. doi: 10.3389/fimmu.2023.1306025. eCollection 2023.
3
The Molecular Breakthroughs in mRNA Biology and Pharmacology that Paved Progress to Develop Effective mRNA Vaccines Against COVID-19.mRNA生物学和药理学的分子突破为开发有效的抗COVID-19 mRNA疫苗铺平了道路。
J Assoc Genet Technol. 2024;50(1):5-13.
4
mRNA vaccines: a new era in vaccine development.mRNA 疫苗:疫苗开发的新时代。
Oncol Res. 2024 Sep 18;32(10):1543-1564. doi: 10.32604/or.2024.043987. eCollection 2024.
5
Race with virus evolution: The development and application of mRNA vaccines against SARS-CoV-2.与病毒进化赛跑:针对 SARS-CoV-2 的 mRNA 疫苗的研发与应用。
Biomed J. 2023 Feb;46(1):70-80. doi: 10.1016/j.bj.2023.01.002. Epub 2023 Jan 13.
6
The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.新冠疫苗的快速研发和早期成功为加速癌症治疗机制带来了希望。
Arch Razi Inst. 2021 Mar;76(1):1-6. doi: 10.22092/ari.2021.353761.1612. Epub 2021 Mar 1.
7
Learning from cancer to address COVID-19.从癌症中学习以应对 COVID-19。
Biol Futur. 2023 Jun;74(1-2):29-43. doi: 10.1007/s42977-023-00156-5. Epub 2023 Jul 6.
8
Transforming vaccinology.疫苗学的变革。
Cell. 2024 Sep 19;187(19):5171-5194. doi: 10.1016/j.cell.2024.07.021.
9
From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases.从流感到 COVID-19:脂质纳米颗粒 mRNA 疫苗在传染病前沿。
Acta Biomater. 2021 Sep 1;131:16-40. doi: 10.1016/j.actbio.2021.06.023. Epub 2021 Jun 18.
10
COVID-19 mRNA vaccines: Platforms and current developments.COVID-19 mRNA 疫苗:平台和当前进展。
Mol Ther. 2022 May 4;30(5):1850-1868. doi: 10.1016/j.ymthe.2022.02.016. Epub 2022 Feb 19.

引用本文的文献

1
Neoantigen mRNA vaccines and AA receptor antagonism: A strategy to enhance T cell immunity.新抗原mRNA疫苗与AA受体拮抗作用:增强T细胞免疫的一种策略。
Hum Vaccin Immunother. 2025 Dec;21(1):2458936. doi: 10.1080/21645515.2025.2458936. Epub 2025 Jan 30.
2
Developing an enhanced chimeric permuted intron-exon system for circular RNA therapeutics.开发用于环状 RNA 治疗的增强型嵌合改组内含子-外显子系统。
Theranostics. 2024 Sep 9;14(15):5869-5882. doi: 10.7150/thno.98214. eCollection 2024.
3
Application of Mammalian Nudix Enzymes to Capped RNA Analysis.

本文引用的文献

1
mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum.表达恶性疟原虫环子孢子蛋白(PfCSP)和Pfs25的mRNA-脂质纳米颗粒候选疫苗,用于靶向恶性疟原虫的感染和传播。
NPJ Vaccines. 2022 Dec 1;7(1):155. doi: 10.1038/s41541-022-00577-8.
2
Progress in Prophylactic and Therapeutic EBV Vaccine Development Based on Molecular Characteristics of EBV Target Antigens.基于EBV靶抗原分子特征的预防性和治疗性EBV疫苗研发进展
Pathogens. 2022 Jul 30;11(8):864. doi: 10.3390/pathogens11080864.
3
The legacy of mRNA engineering: A lineup of pioneers for the Nobel Prize.
哺乳动物Nudix酶在带帽RNA分析中的应用。
Pharmaceuticals (Basel). 2024 Sep 11;17(9):1195. doi: 10.3390/ph17091195.
4
Decoding trends in mRNA vaccine research: A comprehensive bibliometric study.解码 mRNA 疫苗研究趋势:一项全面的文献计量学研究。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2355037. doi: 10.1080/21645515.2024.2355037. Epub 2024 May 30.
信使核糖核酸工程的传承:诺贝尔奖的先驱阵容。
Mol Ther Nucleic Acids. 2022 Sep 13;29:272-284. doi: 10.1016/j.omtn.2022.07.003. Epub 2022 Jul 13.
4
The mRNA vaccine development landscape for infectious diseases.传染病的信使核糖核酸疫苗研发概况
Nat Rev Drug Discov. 2022 May;21(5):333-334. doi: 10.1038/d41573-022-00035-z.
5
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
6
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
7
Characteristics of SARS-CoV-2 and COVID-19.SARS-CoV-2 和 COVID-19 的特征。
Nat Rev Microbiol. 2021 Mar;19(3):141-154. doi: 10.1038/s41579-020-00459-7. Epub 2020 Oct 6.
8
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.《 老年人中新型冠状病毒 mRNA-1273 疫苗的安全性和免疫原性》
N Engl J Med. 2020 Dec 17;383(25):2427-2438. doi: 10.1056/NEJMoa2028436. Epub 2020 Sep 29.
9
SARS-CoV-2 vaccines in development.正在研发中的 SARS-CoV-2 疫苗。
Nature. 2020 Oct;586(7830):516-527. doi: 10.1038/s41586-020-2798-3. Epub 2020 Sep 23.
10
Clinical features of patients with coronavirus disease 2019 from a designated hospital in Beijing, China.中国北京一家指定医院的 2019 冠状病毒病患者的临床特征。
J Med Virol. 2020 Oct;92(10):2055-2066. doi: 10.1002/jmv.25966. Epub 2020 Jun 12.